Le Lézard
Classified in: Health
Subject: PSF

Woolfson Eye Institute Announces a HIPAA Security Incident


ATLANTA, March 29, 2021 /PRNewswire/ -- On September 21, 2020, the Woolfson Eye Institute ("we" or "Woolfson Eye") learned that a laptop that was connected to testing equipment and storing a patient database was stolen earlier that day. The information stored in the patient database on the laptop included patient names and dates of birth only. The information on the laptop did not include any medical diagnoses, Social Security numbers, financial account numbers, drivers' license numbers, or any other more sensitive identifiers or medical information. We sincerely apologize for this situation and any inconvenience it may cause you.

We investigated the incident and have been cooperating with local law enforcement. At this point, we have not received any information suggesting that any patient information has been used for an improper purpose. Nonetheless, we are sending this advisory to update you about the incident so that you can take appropriate steps to protect yourself and minimize the possibility of any misuse of your information.

We recommend you remain vigilant and consider taking steps to protect your personal information, including, without limitation: only sharing your health insurance cards with your health care providers and other family members who are covered under your insurance plan or who help you with your medical care; reviewing your "explanation of benefits statement" which you receive from your health insurance company and following up with your insurance company or care provider for any items you do not recognize; and asking your insurance company for a current year-to-date report of all services paid for you as a beneficiary, and following up with your insurance company or the care provider for any items you do not recognize.

Woolfson Eye treats all sensitive patient information in a confidential manner and is proactive in the careful handling of such information. We are assessing and modifying our privacy and data security policies and procedures to prevent similar situations from occurring in the future.

If you have any further questions, please contact our compliance officer at [email protected].

SOURCE Woolfson Eye Institute


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: